Donor composition and fiber promote strain engraftment in a randomized controlled trial of fecal microbiota transplant for ulcerative colitis
Authors:
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Citizens United for Research in Epilepsy
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK128257)
This publication has 56 references indexed in Scilit:
- Rigorous Donor Selection for Fecal Microbiota Transplantation in Active Ulcerative Colitis: Key Lessons From a Randomized Controlled Trial Halted for FutilityClinical Gastroenterology and Hepatology, 2024
- Human gut microbiota stimulate defined innate immune responses that vary from phylum to strainCell Host & Microbe, 2022
- Gut-microbiota-targeted diets modulate human immune statusCell, 2021
- The Adequacy of Habitual Dietary Fiber Intake in Individuals With Inflammatory Bowel Disease: A Systematic ReviewJournal of the Academy of Nutrition and Dietetics, 2021
- Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative ColitisJAMA, 2019
- The Impact of Dietary Fiber on Gut Microbiota in Host Health and DiseaseCell Host & Microbe, 2018
- The Gut Microbiota, Food Science, and Human Nutrition: A Timely MarriageCell Host & Microbe, 2017
- Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in HumansCell, 2016
- The Treatment-Naive Microbiome in New-Onset Crohn’s DiseaseCell Host & Microbe, 2014
- Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trialJournal of Gastroenterology, 2002